Harm Reduction

AIDS Vancouver launches campaign to have injectable HIV treatment covered in B.C.

By

Although it was approved for use in Canada in March 2020, an injectable HIV treatment is still not covered under B.C.’s public health care system. AIDS Vancouver is calling on the government to change that. “It’s stressful,” said Vancouver resident George Astakeesic. Living with HIV has been a long journey for Astakeesic, who navigates a […]

AIDS Vancouver launches campaign to have injectable HIV treatment covered in B.C. Read More »

BC-CfE researchers attend world’s most influential meeting on HIV research

By

The 11th International AIDS Society (IAS) Conference on HIV Science took place from July 18th to the 21st and BC-CfE researchers attending the virtual conference used the opportunity to present their latest findings. Taking place virtually from Berlin, IAS 2021 saw around 6,000 participants and opened with remarks from German Chancellor Angela Merkel and included

BC-CfE researchers attend world’s most influential meeting on HIV research Read More »

BOOST and Coast Mental Health Collaboration Improves Lives of Those Living With OUD

Uncategorized / By

More than 1,300 people have died from illicit drug poisoning in BC so far this year. Some months saw a death toll greater than double the same month the previous year, and June alone had 183 people die of an overdose. This was the highest monthly overdose related death toll in BC’s history.

BOOST and Coast Mental Health Collaboration Improves Lives of Those Living With OUD Read More »

BC-CfE launches BOOST Quality Improvement Network building on previous BOOST Collaboratives

By

With BC in the midst of two public health emergencies, one for COVID-19 and one for drug overdose deaths, the BC Centre for Excellence in HIV/AIDS (BC-CfE) has just launched a new Quality Improvement Network for its BOOST Collaborative (Best-Practices in Oral Opioid agoniSt Therapy). Led by Dr. Rolando Barrios, the BC-CfE’s Senior Medical Director,

BC-CfE launches BOOST Quality Improvement Network building on previous BOOST Collaboratives Read More »

BC Centre for Excellence in HIV/AIDS invites the “Berlin Patient”, the first person to be cured of HIV, to Vancouver

By

“It’s extraordinary story,” begins Dr. Zabrina Brumme, Laboratory Director at the BC Centre for Excellence in HIV/AIDS (BC-CfE) and Professor of Health Sciences at SFU. Timothy Brown, known worldwide as the “Berlin patient” and the first person to be cured of HIV, was introduced by Dr. Brumme to a conference room in Vancouver. Attendees included

BC Centre for Excellence in HIV/AIDS invites the “Berlin Patient”, the first person to be cured of HIV, to Vancouver Read More »

Teams from across the province share ideas to BOOST engagement in lifesaving OAT

Uncategorized / By

BC-CfE’s provincial BOOST Collaborative is following on the heels of the successful Vancouver-based BOOST Collaborative. BOOST is inspired by the made-in-BC Treatment as Prevention¨ strategy and supports a Targeted Disease Elimination¨ (TDE¨ ) approach. This means using tools and strategies that have been proven through the work of the BC-CfE in curbing HIV transmissions. The TDE¨ strategy can address contagious diseases and diseases with a social contagion factor, such as substance use disorders.

Teams from across the province share ideas to BOOST engagement in lifesaving OAT Read More »

BC-CfE announces provincewide initiative to increase access to lifesaving treatment for opioid use disorder

By

On January 17th, the BC-CfE announced the launch of a provincewide initiative, supported by a funding grant from Health Canada’s Substance Use and Addiction Program. The first-of-its-kind initiative based on the BC-CfE’s world-renowned Treatment as Prevention (TasP) strategy to curb HIV and AIDS—will roll out across all BC regional health authorities in early 2019. This

BC-CfE announces provincewide initiative to increase access to lifesaving treatment for opioid use disorder Read More »

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search